List of works - Graham R Foster

Are all Type I human interferons equivalent? ⬇️

scientific article published on May 1, 1998

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis ⬇️

scientific article published on January 1, 1998

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha ⬇️

scientific article published on March 1, 1995

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed

scientific article published on 22 May 2020

Expression of the terminal protein of hepatitis B virus is associated with failure to respond to interferon therapy ⬇️

scientific article published on May 1, 1993

Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA ⬇️

scientific article published on April 1, 1991

High yield expression, refolding, and characterization of recombinant interferon α2/α8 hybrids in Escherichia coli ⬇️

scientific article published on October 1, 2003

Increase in primary liver cancer in the UK, 1979–94 ⬇️

scientific article published on October 18, 1997

Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene ⬇️

scientific article published on August 25, 1991

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients ⬇️

scientific article published on July 1, 2011

Interferons in Host Defense ⬇️

scientific article published on January 1, 1997

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm ⬇️

scientific article published on August 23, 1997

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus ⬇️

scientific article published on May 1, 2003

Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response ⬇️

scientific article published on January 1, 1993

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

scientific article published in PLoS ONE

Serum F-protein concentration following halothane or isoflurane anaesthesia ⬇️

scientific article published on October 14, 1991

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

scientific article published on 9 February 2018

Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene

scientific article published on 01 August 1998

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

scientific article

Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure ⬇️

scientific article published on November 23, 2012

The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England

scientific article published on 12 March 2019

The relationship of histology to genotype in chronic HCV infection ⬇️

scientific article published on June 1, 1997

Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care ⬇️

scientific article published on April 1, 2011

Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: ‘Lead‐in or no lead‐in’? ⬇️

scientific article published on February 1, 2012

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients ⬇️